Replies to post #129987 on Vivos Inc (RDGL)

[wrinklesobw]

My short term I’m guessing
Up to December.16/17th we will could see a little run and probably get to about .20 cents maybe a little higher, there will be some that thinks the fda might give the ok on the device approval on one of those dates.

If the fda asks for more information there will be a pull back to .12-.15 cents then come January 17th ish. It will run pretty hard to around .50 before the announcement.

Now if they approve it in December this will easily hit 1 dollar possibly even as high as 5 bucks. If they don’t approve it in December we will float around .12-.20 until the week before they give the final word in January which I could see a run up to about a dollar. Before they say anything in January.

Either date if approved I easily see us in the 2.50 - $5 range. Then float in this range until they get the ok to move forward with human testing, then we will gradually go higher maybe even as high as 20 dollars a share during human testing. Which remember if the break through device is approved it will shorten the amount of time they need to do the testing.
Approval with this at the end of human testing will shoot us into the $50 dollar range. Reason because since they changed from skin cancer to a more difficult cancer which means cancers that are easier to get to and treat will be fast tracked approved quickly.

We get denied it will fall back to around .02 and we will have to wait tell spring when they plan to do the original submittal for human test then everything will be extended by years and not months.

So buy June/July around $5 plus